Perrigo Company plc Increase (Decrease) in Employee Related Liabilities
Perrigo Company plc (PRGO) reported Increase (Decrease) in Employee Related Liabilities of -$45.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-05
- Perrigo Company plc increase (decrease) in employee related liabilities for the quarter ending 2026-06-27 was -$20.10M.
- Perrigo Company plc increase (decrease) in employee related liabilities for the quarter ending 2026-03-28 was -$24.90M.
- Perrigo Company plc increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$24.70M.
- Perrigo Company plc increase (decrease) in employee related liabilities for the quarter ending 2025-09-27 was -$15.10M.
- Perrigo Company plc increase (decrease) in employee related liabilities for fiscal 2025 was -$63.40M.
- Perrigo Company plc increase (decrease) in employee related liabilities for fiscal 2024 was -$94.40M.
- Perrigo Company plc increase (decrease) in employee related liabilities for fiscal 2023 was -$52.80M.
- Perrigo Company plc increase (decrease) in employee related liabilities for fiscal 2022 was -$38.20M.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-27 | -$20.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$45.00M 10-Q · filed 2026-08-05 | -$69.70M derived: sum of 3 quarters · filed 2026-08-05 | -$84.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-28 | -$24.90M 10-Q · filed 2026-05-06 | -$49.60M derived: sum of 2 quarters · filed 2026-05-06 | -$64.70M derived: sum of 3 quarters · filed 2026-05-06 | -$69.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$24.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$39.80M derived: sum of 2 quarters · filed 2026-02-26 | -$45.00M derived: sum of 3 quarters · filed 2026-08-05 | -$63.40M 10-K · filed 2026-02-26 |
| 2025-09-27 | -$15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$20.30M derived: sum of 2 quarters · filed 2026-08-05 | -$38.70M 10-Q · filed 2025-11-05 | -$59.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-28 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$23.60M 10-Q · filed 2026-08-05 | -$44.10M derived: sum of 3 quarters · filed 2026-08-05 | -$48.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-29 | -$18.40M 10-Q · filed 2026-05-06 | -$38.90M derived: sum of 2 quarters · filed 2026-05-06 | -$43.20M derived: sum of 3 quarters · filed 2026-05-06 | -$61.20M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$24.80M derived: sum of 2 quarters · filed 2026-02-26 | -$42.80M derived: sum of 3 quarters · filed 2026-02-26 | -$94.40M 10-K · filed 2026-02-26 |
| 2024-09-28 | -$4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$22.30M derived: sum of 2 quarters · filed 2025-11-05 | -$73.90M 10-Q · filed 2025-11-05 | -$74.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-29 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$69.60M 10-Q · filed 2025-08-06 | -$69.70M derived: sum of 3 quarters · filed 2026-02-26 | -$79.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-30 | -$51.60M 10-Q · filed 2025-05-07 | -$51.70M derived: sum of 2 quarters · filed 2026-02-26 | -$61.90M derived: sum of 3 quarters · filed 2026-02-26 | -$70.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.30M derived: sum of 2 quarters · filed 2026-02-26 | -$18.50M derived: sum of 3 quarters · filed 2026-02-26 | -$52.80M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$18.40M derived: sum of 2 quarters · filed 2024-11-06 | -$52.70M 10-Q · filed 2024-11-06 | -$50.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-07-01 | -$8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$42.50M 10-Q · filed 2024-08-02 | -$40.20M derived: sum of 3 quarters · filed 2025-02-28 | -$41.90M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-04-01 | -$34.30M 10-Q · filed 2024-05-07 | -$32.00M derived: sum of 2 quarters · filed 2025-02-28 | -$33.70M derived: sum of 3 quarters · filed 2025-02-28 | -$40.70M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $600.00K derived: sum of 2 quarters · filed 2025-02-28 | -$6.40M derived: sum of 3 quarters · filed 2025-02-28 | -$38.20M 10-K · filed 2025-02-28 |
| 2022-10-01 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$8.70M derived: sum of 2 quarters · filed 2023-11-07 | -$40.50M 10-Q · filed 2023-11-07 | -$32.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$38.80M 10-Q · filed 2023-08-08 | -$31.20M derived: sum of 3 quarters · filed 2024-02-27 | -$30.70M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | -$31.80M 10-Q · filed 2023-05-09 | -$24.20M derived: sum of 2 quarters · filed 2024-02-27 | -$23.70M derived: sum of 3 quarters · filed 2024-02-27 | -$38.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $8.10M derived: sum of 2 quarters · filed 2024-02-27 | -$7.10M derived: sum of 3 quarters · filed 2024-02-27 | -$53.00M 10-K · filed 2024-02-27 |
| 2021-10-02 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$14.70M derived: sum of 2 quarters · filed 2022-11-08 | -$60.60M 10-Q · filed 2022-11-08 | -$47.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | -$15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$61.10M 10-Q · filed 2022-08-09 | -$48.10M derived: sum of 3 quarters · filed 2023-02-28 | -$29.90M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | -$45.90M 10-Q · filed 2022-05-11 | -$32.90M derived: sum of 2 quarters · filed 2023-02-28 | -$14.70M derived: sum of 3 quarters · filed 2023-02-28 | -$16.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $31.20M derived: sum of 2 quarters · filed 2023-02-28 | $29.20M derived: sum of 3 quarters · filed 2023-02-28 | $10.80M 10-K · filed 2023-02-28 |
| 2020-09-26 | $18.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $16.20M derived: sum of 2 quarters · filed 2021-11-12 | -$2.20M 10-Q · filed 2021-11-12 | $4.70M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$20.40M 10-Q · filed 2021-08-11 | -$13.50M derived: sum of 3 quarters · filed 2022-03-01 | -$1.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | -$18.40M 10-Q · filed 2021-05-12 | -$11.50M derived: sum of 2 quarters · filed 2022-03-01 | $900.00K derived: sum of 3 quarters · filed 2022-03-01 | -$2.20M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $19.30M derived: sum of 2 quarters · filed 2022-03-01 | $16.20M derived: sum of 3 quarters · filed 2022-03-01 | -$3.70M 10-K · filed 2022-03-01 |
| 2019-09-28 | $12.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.30M derived: sum of 2 quarters · filed 2020-11-05 | -$10.60M 10-Q · filed 2020-11-05 | -$4.30M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-29 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$23.00M 10-Q · filed 2020-08-05 | -$16.70M derived: sum of 3 quarters · filed 2021-03-01 | -$9.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-30 | -$19.90M 10-Q · filed 2020-05-05 | -$13.60M derived: sum of 2 quarters · filed 2021-03-01 | -$6.00M derived: sum of 3 quarters · filed 2021-03-01 | -$15.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $13.90M derived: sum of 2 quarters · filed 2021-03-01 | $4.40M derived: sum of 3 quarters · filed 2021-03-01 | -$34.50M 10-K · filed 2021-03-01 |
| 2018-09-29 | $7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$1.90M derived: sum of 2 quarters · filed 2019-11-06 | -$40.80M 10-Q · filed 2019-11-06 | -$31.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$48.40M 10-Q · filed 2019-08-08 | -$39.10M derived: sum of 3 quarters · filed 2020-02-27 | -$37.90M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$38.90M 10-Q · filed 2019-05-09 | -$29.60M derived: sum of 2 quarters · filed 2020-02-27 | -$28.40M derived: sum of 3 quarters · filed 2020-02-27 | -$56.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $10.50M derived: sum of 2 quarters · filed 2020-02-27 | -$17.30M derived: sum of 3 quarters · filed 2020-02-27 | -$27.40M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$26.60M derived: sum of 2 quarters · filed 2018-11-08 | -$36.70M 10-Q · filed 2018-11-08 | -$37.80M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-07-01 | -$27.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$37.90M 10-Q · filed 2018-08-09 | -$39.00M derived: sum of 3 quarters · filed 2019-02-27 | -$39.80M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-04-01 | -$10.10M 10-Q · filed 2018-05-08 | -$11.20M derived: sum of 2 quarters · filed 2019-02-27 | -$12.00M derived: sum of 3 quarters · filed 2019-02-27 | -$13.80M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$1.90M derived: sum of 2 quarters · filed 2019-02-27 | -$3.70M derived: sum of 3 quarters · filed 2019-02-27 | -$41.10M 10-K · filed 2019-02-27 |
| 2016-10-01 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$2.60M derived: sum of 2 quarters · filed 2017-11-09 | -$40.00M 10-Q · filed 2017-11-09 | -$55.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-07-02 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$39.20M 10-Q · filed 2017-08-10 | -$54.60M derived: sum of 3 quarters · filed 2018-03-01 | -$77.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-04-02 | -$37.40M 10-Q · filed 2017-05-30 | -$52.80M derived: sum of 2 quarters · filed 2018-03-01 | -$75.60M derived: sum of 3 quarters · filed 2018-03-01 | -$78.40M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$15.40M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | -$38.20M 10-K · filed 2018-03-01 | -$41.00M derived: sum of 3 quarters · filed 2018-03-01 | -$42.00M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-09-26 | -$22.80M 10-Q · filed 2015-11-02 | -$25.60M derived: sum of 2 quarters · filed 2017-05-22 | -$26.60M 10-Q/A · filed 2017-05-23 | -$18.00M derived: sum of 4 quarters · filed 2017-05-22 |
| 2015-06-27 | -$2.80M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$3.80M 10-Q/A · filed 2017-05-22 | $4.80M derived: sum of 3 quarters · filed 2017-05-22 | -$30.20M 10-K · filed 2018-03-01 |
| 2015-03-28 | -$1.00M 10-Q/A · filed 2017-05-22 | $7.60M derived: sum of 2 quarters · filed 2017-05-22 | -$27.40M 10-Q · filed 2015-04-29 | -$42.50M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-12-27 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | -$26.30M 10-Q · filed 2015-02-05 | -$41.50M derived: sum of 3 quarters · filed 2017-05-22 | -$95.50M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-09-27 | -$34.90M 10-Q · filed 2015-11-02 | -$50.10M derived: sum of 2 quarters · filed 2017-05-22 | -$104.10M derived: sum of 3 quarters · filed 2017-05-22 | -$81.80M derived: sum of 4 quarters · filed 2017-05-22 |
| 2014-06-28 | -$15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | -$69.20M derived: sum of 2 quarters · filed 2017-05-22 | -$46.90M derived: sum of 3 quarters · filed 2017-05-22 | -$55.50M 10-K · filed 2017-05-22 |
| 2014-03-29 | -$54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | -$31.70M derived: sum of 2 quarters · filed 2015-04-29 | -$40.30M 10-Q · filed 2015-04-29 | -$30.80M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-28 | $22.30M derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $13.70M 10-Q · filed 2015-02-05 | $23.20M derived: sum of 3 quarters · filed 2016-02-25 | $21.80M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-28 | -$8.60M 8-K · filed 2014-11-20 | $900.00K derived: sum of 2 quarters · filed 2016-02-25 | -$500.00K derived: sum of 3 quarters · filed 2016-02-25 | |
| 2013-06-29 | $9.50M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $8.10M derived: sum of 2 quarters · filed 2016-02-25 | -$11.90M 10-KT · filed 2016-02-25 | |
| 2013-03-30 | -$1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | -$21.40M 10-Q · filed 2014-05-07 | ||
| 2012-12-29 | -$20.00M 10-Q · filed 2014-02-06 | |||
| 2012-06-30 | $5.00M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |